Since the introduction of percutaneous tratiuminal coronary angioplasty into clinical practice by Andreas Gtuentzig in 1977 (I ,2), the efficacy of this technique in the treatment of coronary artery disease, both native and vein graft vessels, has cleariy become established (L6), with continuing grawth such that the number of angioplasties performed per year equals that of coronary artery bypass operations. The immediate and mediiterm outcomes are well dexrii, with the problems of abrupt closure and restenosis antinuing to elude attempts to reduce U Am Gd Gdid 1~27: their frequency (7) (8) (9) (10) . Knowkdge of tbe long-tena outoome of coronary ang&L&y continues to accumulate Over time (11) Data presented are number (5) of patients, unless chemise indited CABG = mronaty artery bypass graft surgery EF = ejection fraction; MI = myncatdial infarction.
nitrates and, in patients in unstable condition, intravenous heparin.
Aagiopfasty teehniqoe. At the commencement of the angiopIasty procedure, w) mg of acetyisalicylic acid and 100 mg of heparin were administered intravenously, with additional bolusesof5Omggivenhourly.Aiiercompletionoftheprocedure, if the stability of the immediate result was in doubt, a heparin infusion was commenced to achieve an activated partial thromboplastin time of 2.0 to 2.5 times control levels for 12 to 24 h. AU patients continued to receive both nifediiine (40 to 60 mg) and acetylsahcylic acid (500 mg) once daily for a period of at least 6 months. The method of coronary angioplasty changed in February 1983 when the nonst~rable catheter system originally described by Gruentzig (2) was replaced by steerable balloon systems (13) . Pmc&mrl clinhl SACC~S was de&d a3 a reduction in the lumen narrowing to <SO% of the reference diameter, by visual afsesnmc with no major aaoplior~(death,myomrdialinfarction,coronarybypasssurgeIyorrepeat~)within24hoftheprocedcre.Evidence of myocardial infarction immediately after the procedure was defined by a new Q wave or elevation of myocardial enzyme levels to more than twice the upper limit of normal, or both.
Data collection and folioa-op. Procedural details, including com$cations, were recorded at the time of the procedure and entered into a dedicated data base. Procedure-related events were included in all follow-up analyses. In 1994 all patients who survived the hospital period were initially checked against the civil registry to establish survival or death. This is a reliable and complete source of mortality data in The Netherlands. Primary end points considered at follow-up were death, nonfatal myocardial infarction, rexxrrent angina pectoris requiring coronary artery bypass surgery or repeat angio= plasty and event-free survival. These data were retrospectively obtained from the patient by letter or telephone. from the family or from the family doctor and checked against hospital records.
Assessment of late myozardial infarction during the followup period included a history of prolonged chest pain necessitating hospital admission and documentation of a myocardial infarction by electrocardiographic (ECG) or enzyme criteria. Information on bypass surgery and repeat angioplasty was obtained from the patient and hospital data bases. Additionally, surviving patients were asked for information regarding symptoms of angina pectoris, graded according to Canadian Cardiovascular Society classification (14) , any resultant limitation in activities and current medication. Follow-up data were obtain& for all but 19 patients (2.2%), the majority of whom had moved abroad. The follow-up period ranged from 0 to 13.3 years (median 9.6).
Statistical methods. Patient smvivai curves were constructed according to the method of Kaplan and Meier (15) . Mean values were calculated for continuous variables and absolute and relative frequencies for discrete variables. Differences between groups were examined for statistical significance by use of a two-sample t test for continuous variables and the &i-square teat for discrete variables; p c: 0.05 was consiaered signiticant. Multivariate logistic regression using a computer package (BMDP) was performed to identify factors that ----yy Nival rates in 856 patients who mKlerwent eotm angioplastyduringtk~i985t01985IWtkn beIawgrqh=patkntsatrisk25,5,7.5and1Oyears OaAw afterangi~~b=lSE.cAl3G= cABGIREprcA cwttaryartery~surge~,MI=iqcar&I infarction; REPTCA = repeat c~mnaty aqi@asq.
LONG-TERM OLTCOME AFIER CORONARY ASGIOf'LAST3 were related to long-term survival. A forward-and backwardstepping algorithm was used with p < 0.05 to identify the variabks remaining as independent ri& factors for long-term survival. Baseline characteristics tested were age 260 yeagender, prior myocardial infarction, unstable angina multivessel dii, ejection fradi 40% and procedural failure. Elesub. During the years 1980 to 1985,969 consecutive coronary angiopiasties were performed in 856 patients. The procedurai success rate was 82%. Lung-term fouow-up information was obtained for 837 patients (97.8%).
!kv+al rud symptoms. Sii-hundred forty-one patients (77%) were aliie and 1% dead 8 to 14 years after theii initial x@oplasty. One hundred forty-three patients had experienced a lnyoeardia &r&n, and 220 (25.7%) had undergorte corunary artery bypass surgery, iu 62 (7.2%) as an emergency procedure immediately after balloon angiophtsty. Two hundred twenty-one patients underwent further angiopkty in the follow-up period, 81 (9.5%) withic 6 months of the initial procedure. Patient survival and event-free survival curves were calculated using ranked clinical events and are displayed in took significantly more antianginal medication (70% at least one antiangina agent vs 57% of men).
Sinbiliry ofungine Fcur hundred fifty-one patients underwent coronary angioplasty for stable angina, 323 for unstable angina and 76 for an acute myocardial infarction. When survival curves were calculated for patients with stable and unstable angina and compared. there were no differences in long-term survival and cardiac event rates (Fig. 4) . The two groups were similar with respect to other clinical variables. There were also no diierellces in symptoms and amount of antianginal therapy between the survivors of the two groups at the time of follow-up.
plevious myocardial infior. Of 833 pa:ients with documented &ails, 341 had a prevkus myocardiai infarction (23 patienis unkmmnj. A sign&an; survivai beneM for those without a previous myocardial inf: rction was detectable only 9 years afker the index angioplasty (Fig. 5) .
Mdivessel direme. An&~hsty was performed in 517 patients with single-vessel disease, 193 with two-vessel disease, 96 with three-vessel disease and 11 with mainstem disease (39 not recorded). When patients were class&d into two groupsthose with sings-vessel disease and those with multivessel and mainstem disease-and survival curves constructed, a clear survival advantage was detectable for those with one-vessel disease by 1 year after the intervention, with 84% alive at 10 years versus 69% of those with multivessel disease (Fig. 6) . However, there was no difference in survival or cardiac event rates when patients who underwent single-lesion (n = 672) and multiple-lesion (n = 184) angioplasty were compared.
L& ~~enentricuiar function Left ventricular ejection fraction had been calculated in 629 patients: mean [?SD] 59 z II%> range 19% to 86%; ~50% in 525, <50% in 104. Survival and event-free survival curves were constructed for these two groups (Fig. 7) . There was a dear survival advan:age for those with ejection fraction rSO%, with &WY0 remaining alive IO years after angioplasty compared with 57% of those with ejection fraction ~50%. However, event-free survival was similar, with less myocardial infarction, coronary artery bypass surgery and repeat ~ngioplasty occurring in the follow-up period in patients wrtn impaired left ventricular function.
Proceduml success. Anghplasty was suazssful in 700 patients (82%). When these patients were compared with those with unsuccessful angioplasty with or without a complication, long-term smvival was similar. However, significantly more Fii 5. Cumulative survival and event-free survival rates for patientr who underwent coronary angioplasty during the study period classified according to a positive or negative history for previous myocardii infarction. Format and abbrevip~mtls as in Figure 1. major events occurred in patients with a procedural failure, predominantly about the time the angioplasty was performed (Fig. 8) .
The 5-and IO-year cumulative survival rates for the various subgronps evaluated are shown in Table 3 . Univariate analyses were used to test the it&em-z of the previous seven clinical factors on long,-term survival. The odds ratios (ORs) for these variables, with 95% confidence intervals (Cfs), are displayed in Fii 9. Multivariate analy+ could he performed for 579 patients with complete data. Age ~60 years (OR 2.42,95% Cl 1.62 to 3.&J), ejection fraction <50% (OR 2.22,9X CI 1.33 to 3.70), multivessel disease (OR 1.60,95% Cl 1.06 to 2.42) and a history of previous myocardial infarction (OR 154.95% Cl 1.00 to 2.37) were found to be independent predictors of a diminished long-rerm survival.
Discussion
In patient m;inagement an inevitable question is, What is the prognosis?. The answer can be given only in the light of temporal information gained from similar groups of patients treated by similar means in the past. This also holds true for the management of coronary artery dii by coronary angioplasty. ReExdless of an cvokving change in patient characteristics, procedural indications. technique and expertise, knowledge of the long-term outcome of early angioplasty practice remains an important source of information and guidance for contemporary card&g& and patients. In the present study, we examined the late clinical outcome of the first 856 patients who undetxwxtt attempted angio@asty in a single center during the years 1980 to 1985. Our patient groupkhuied76whounderwentcoronarya@opktyforan evoh-iug acute myocardial infanxion and 156 (18%) in whom the procedure was an angiographic failure: thus, this wac an intention to treat anairjis. Our finding cf an overall S-year survival rate of 90%. although favorable. appears to he kcr than prevkmsly reported (Table 4 ). It is recognized that rbe prognusis of p&cuts with single-vessel disease and good ventricular function is excellent even w$en managed conservatively (17) . When our patients mre compared with oiher studii we found that our patients were older and more likely to have multivessel dkease, both factors associated with a decreased likelihuod of event-free sutGval(l8-20).
We suggest that the bar&x characterktics of our patients more ebsely resemble those of patients encountered in current angioplasty practice. 'fhe KLyear survivat rate of our cohort of patients was 7@%, and to our knowledge, the only reported data for comparisons WC irom Gruenlzig's first 169 patients in whom the Inyear suwivaI was 89.5% (12) . His patients were a highly selecteci group in whom only proximal, discrete, predominantly left anterior dezending artery kskms (73%) were treated because of the Emitations of the equipment available at the time. Furthermore. his patients were younger and had a mean age of 49.8 lean compared with 563 years in our study. In our study, 543 patknts were <60 years 016 with a IO-year survival rate of 85%. Onty 36% of our patients were free from further cardiac events 10 years after the index procedure (57% event free at 5 years), no doubt a result of our more general patient cohort (myoeardid infarction in 41%, prior copnary bypass surgery in 956, multiverse disease h X.7%, imp&cd left ventrkular function in 165%). Vii all patients with angiograpbkdly unswesU angioplasty early in the study period were referred for semiurgent mmnary bypass surgery. This tendency decreased as eonfkknce in tbe technique grew, witb an overall rate of 7.2% over the 5-year period. Recent data (21) show that the emeq?ncy bypass surgery rate is now <I%, and it along with an impmved pmeedurai success rate (now >%) are most liily ihe most changed factors when our study patients Fire 7. Cumulative survival and event-free Uliviva1 rates for the 629 patients with a calculated ejection trxtion (EF), classified into those with cjecfion fraction 40% and 30%. Format and other abbreviations as in Figure 1 .
are compared with those of :he present day because the rates of death, myocardial infarction, restencis and repeat intervention have changed little in the past decade (213). The long-t-;-n? outcome of patients undergoing contemporary angioplasty may therefore be Ir.ore eomparablc to patients in the present study with a successful procedure.
F&JR? survival We tested the dinid factors of age, gender, previous myocardial infarction, stabiity of angina, multivessel disca~ and left ventricular function to asses whether they influenced long-term survival. Although coronary angioplasty has been shown to be safe and effective in elderly patients with coronary artery disease (B), our data, in agreement with others, show signifnxntly reduced long-term survivalinpatientsr60yearsoldatthetime,oftheitirst angioplasty procedure (24) . This result may bc explained by the more extensive coronary artery disease, with possibiy less complete revascularization, in this group of patients. Additionally, it is possible that more deaths resulted from other disease processes more likely to manifest with advancing years because our mortality data included deaths from all causes.
The finding that men and women have a similar outcome after angioplasty in the intermediate term (16JS) (33) . In both studies, patients who underwent coronary angioplasty required significantly more revascularization procedures in the fohow-up period (3 years for EAST, 1 year for GABI), with an increased need for anginaI therapy, than those who underwent operation. Continued long-term follow-up of these groups of patients is essential to establish whether those assigned to coronary angioplasty obtain a survivaI benefit once vein graft disease becomes advanced, as is suggested by tbe CA.% registry data, thus perhaps justhying the frequent need for earIy reintervention.
CnneInsIuna, Long-term smvivaI in our timt 856 patients who underwent attempted coronary angiopIasty during the years 1980 to 1985 is good, partiadarIy in those patients <6B years old at tbe time of intervention and those with singfevessel disease and normaI left ventricular fnnction. The long term outcome in terms of survival and freedom from cardiac events was simdar in men and women and those with stable and unatabk angina. The majority of patients experienced a further cardiac evem most Iikely as a result of procedural failure and restenosis in the eariy follow-up period and incompletcness of rcvaaadarization and progression of atherosclerosis subsequentIy. Although significant advances have occurred, partictdarly in improving tbe immediate success of coronary ang@kty ~jd in the compkxity of h&is treated, making comparison with current practice difficult, knowledge of long-term outcome remains essential in planning treatment strategies.
